Renalytix Plc Stock OTC Markets
Stocks
RNLXY
US75973T2006
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
OTC Markets
20:45:20 18/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 4.150 USD | 0.00% |
|
-1.19% | +14.64% |
| 09-08 | EARNINGS AND TRADING: Acuity eyes 'breakeven' as loss narrows | AN |
| 09-08 | FTSE 100 slips as Bailey flags inflation risks | AN |
| Market Cap | 13.34M 11.63M 10.98M 9.97M 18.68M 1.28B 18.76M 132M 50.76M 651M 50.1M 48.98M 2.09B | P/E 2024 |
-0.45x | P/E 2025 | -1.34x |
|---|---|---|---|---|---|
| Enterprise Value | 17.94M 15.64M 14.77M 13.41M 25.13M 1.72B 25.23M 177M 68.26M 875M 67.38M 65.88M 2.82B | EV / Sales 2024 |
11,059,330x | EV / Sales 2025 | 12,499,418x |
| Free-Float |
79.62% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | -1.19% | ||
| Current month | +56.96% | ||
| 1 month | +46.90% | ||
| 3 months | +260.87% | ||
| 6 months | +116.15% | ||
| Current year | +14.64% |
| 1 week | 4 |  | 4.17 |
| 1 month | 2.55 | | 4.64 |
| Current year | 1 | | 4.64 |
| 1 year | 1 | | 7.5 |
| 3 years | 1 | | 60 |
| 5 years | 1 | | 695.75 |
| 10 years | 1 | | 892.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
James McCullough
CEO | Chief Executive Officer | 58 | 15/03/2018 |
Joel Jung
DFI | Director of Finance/CFO | 68 | 28/05/2024 |
Howard Doran
PSD | President | 65 | 30/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Julian Baines
CHM | Chairman | 62 | 05/11/2024 |
James McCullough
BRD | Director/Board Member | 58 | 15/03/2018 |
| Chairman | 74 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -1.19% | - | - | 50.48M | |
| -0.40% | +6.18% | +20.11% | -26.70% | 17.65B | |
| +0.57% | +7.59% | -44.18% | +28.39% | 1.89B | |
| -0.90% | -1.46% | -32.67% | +20.56% | 870M | |
| -0.27% | +0.16% | +49.84% | -1.12% | 779M | |
| -4.24% | -9.85% | -64.29% | -85.85% | 728M | |
| +1.13% | +0.56% | -36.46% | -50.65% | 642M | |
| -0.97% | -1.08% | -43.47% | -56.37% | 555M | |
| -4.10% | +10.61% | +54.40% | +72.06% | 436M | |
| -2.23% | -1.35% | -44.36% | -38.96% | 439M | |
| Average | -1.14% | +0.93% | -15.68% | -15.40% | 2.67B | |
| Weighted average by Cap. | -0.53% | +4.83% | +8.00% | -21.38% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.29 2 1.88 1.71 3.21 219.64 3.22 22.58 8.71 111.67 8.6 8.41 359.31 | 3 2.62 2.47 2.24 4.2 287.86 4.22 29.59 11.42 146.35 11.27 11.02 470.91 |
| Net income | -33.46M -29.17M -27.55M -25.01M -46.87M -3.21B -47.06M -330M -127M -1.63B -126M -123M -5.25B | -20.4M -17.79M -16.8M -15.25M -28.58M -1.96B -28.7M -201M -77.64M -995M -76.63M -74.93M -3.2B |
| Net Debt | 3.86M 3.36M 3.17M 2.88M 5.4M 370M 5.42M 38.02M 14.67M 188M 14.48M 14.16M 605M | 4.6M 4.01M 3.79M 3.44M 6.44M 441M 6.47M 45.37M 17.51M 224M 17.28M 16.9M 722M |
Employees
46
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | $4.150 | 0.00% | 530 |
| 17/09/26 | $4.150 | -0.48% | 1,200 |
| 15/09/26 | $4.170 | +2.46% | 1,358 |
| 14/09/26 | $4.070 | -3.10% | 7,017 |
| 11/09/26 | $4.200 | +7.69% | 801 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RENX Stock
- RNLXY Stock
Select your edition
All financial news and data tailored to specific country editions
